STUDY QUESTION: Is perinatal mortality rate higher among births born following assisted reproductive technology (ART) compared to non-ART births?
Introduction
Fetal, neonatal and perinatal mortality are important indicators for monitoring pregnancy and childbirth. According to the World Health Organisations (WHO), around 2.6 million stillbirths occurred globally and an additional 2.8 million die in the first week of life (WHO, 2017) . In 2014, a total of 2986 perinatal deaths were reported in Australia (10 per 1000 births), including 2200 fetal deaths (7 per 1000 births) and 786 neonatal deaths (3 per 1000 live births) (Australian Institute of Health and Welfare, 2016) .
A number of recent studies suggest that babies born following assisted reproductive technology (ART) are at greater risk of adverse perinatal outcomes than non-ART infants (Helmerhorst et al., 2004; Halliday, 2007; Halliday et al., 2010; Maheshwari et al., 2012; Henningsen et al., 2014) . Fetal and perinatal mortality is reported to be higher in ART singletons, compared to non-ART singletons (Romundstad et al., 2008; Maheshwari et al., 2012) . A systematic review and meta-analysis of eight studies shows 1.87 times increased risk of perinatal mortality (Relative risk (RR) 1.87, 95% confidence interval (CI), 1.48-2.37) in ART singletons born after IVF/ICSI compared to non-ART singletons (Maheshwari et al., 2012) . In contrast, lower risk of perinatal mortality is reported in ART twins compared to non-ART twins (Helmerhorst et al., 2004; Declercq et al., 2015) .
Preterm birth is an important outcome following ART treatment (Australian Institute of Health and Welfare, 2015) . Overall rate of preterm birth in Australia in 2014 was 8.6% while corresponding rate in ART babies was 16.1% (Australian Institute of Health and Welfare, 2016) . Twin and high order multiple were more likely to be preterm compared to the singletons in both ART (singleton 10.5% and twins 69.3%) and non-ART births (singleton 6.9% vs. multiple 63.0%) (Australian Institute of Health and Welfare, 2016) . The Australian data show that the perinatal mortality rate is the highest among babies born at 20-27 weeks gestation (708 per 1000 births) and lowest among babies born at term (37-41 weeks) (2 per 1000 births) (Australian Institute of Health and Welfare, 2015) . The extent to which preterm birth following ART contributes to the perinatal mortality is not known.
The aim of this study was to compare the fetal, neonatal and perinatal death rates of ART births and non-ART births stratified by plurality and gestational age. The second aim of the study is to compare the causes of perinatal deaths between ART and non-ART births.
Materials and Methods
This population-based retrospective cohort study included all births of ≥20 weeks of gestation and/or ≥400 g of birthweight in five states and 
Participants/materials
The study population comprised of 407 368 births (391 952 non-ART and 15 416 ART births). These babies were born to 386 644 non-ART mothers and 13 732 ART mothers (total 400 376 mothers).
Data
Data used in this study were taken from the National Perinatal Data Collection (NPDC), a population-based cross-sectional data collection of all women giving birth in Australia and their babies. The NPDC includes all births (liveborn or stillborn) of ≥20 weeks of gestation or ≥400 g of birthweight in Australia. It includes data items relating to the mother, including demographic characteristics and factors relating to the pregnancy, labor and birth, and data items relating to the baby, such as birth status, sex, birthweight and Apgar score.
Since 2007, data on whether the pregnancy resulted from ART are available for five of the eight states and territories in Australia: Victoria, Queensland, Western Australia, Tasmania and the Australian Capital Territory (ACT). The ART treatment is the indicator of all types of ART treatment including in-vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). However, detailed type of ART treatment is not specified in the NPDC. Data used in this study include 400 376 births (including 3.4% ART births) from above five states and territories where ART status was available.
Other potential confounders
Maternal age was categorized into seven groups (<20 years, 20-24 years, 25-29 years, 30-34 years, 35-39, 40-44 years and ≥45 years) . Parity was grouped as primiparous and multiparous. BMI at giving birth was divided into four groups (<20, 20-24.9, 25-29.9 and ≥30) . Health insurance included private or public cover. Smoking during pregnancy was grouped as yes, no or not stated. Pre-existing diabetes mellitus and essential hypertension were both coded as yes, no or not stated.
Birth: expulsion or extraction from its mother of a product of conception of 20 or more completed weeks of gestation or 400 g or more birthweight.
Main outcome measures
Primary outcomes were stillbirth, neonatal and perinatal death rates among ART and non-ART births (Australian Institute of Health and Welfare, 2016; Monk et al., 2016) .
(1) Stillbirth: The birth of a baby who is 20 or more completed weeks of gestation or of 400 g or more birthweight who is expelled or extracted from his or her mother and shows no signs of life such as a heartbeat, voluntary muscle movement or pulsation of the umbilical cord. Causes of stillbirth and neonatal death were classified according to the Perinatal Society of Australia and New Zealand Perinatal Death Classification (PSANZ-PDC). The PSANZ-PDC has classified 11 major categories of deaths: congenital abnormality, perinatal infection, hypertension, antepartum hemorrhage, maternal conditions, specific perinatal conditions, hypoxic peripartum death, fetal growth restriction, spontaneous preterm, unexplained antepartum death, no obstetric antecedent (Laws et al. 2010) . However, the PSANZ-PDC data were not available for all states and territories in the study population. The major categories of stillbirth and neonatal death of PSANZ-PDC were presented in the result.
Sample size and study power
To significantly differentiate the perinatal mortality rate of 10 per 1000 births for non-ART births from the rate of 15 per 1000 births for ART births with a study power of 80% (alpha = 0.05), a sample size of 8363 births in each group was required. Inclusion of 13 732 ART mothers and 386 644 non-ART mothers has increased the study power to 99%.
Statistical analysis
The above definitions of birth and perinatal period were used to calculate the stillbirth and neonatal and perinatal death rates:
The stillbirth rate is calculated as the number of stillbirths (numerator) divided by the total number of births (denominator). This is expressed per 1000 births.
The neonatal mortality rate is calculated as the number of neonatal deaths (numerator) divided by the total number of 'live' births (denominator). This is expressed per 1000 'live' births.
The perinatal mortality rate is calculated as the number of stillbirths plus neonatal deaths (numerator) divided by the total number of births (denominator). This is expressed per 1000 births.
The 95% (CI) of above rates was calculated using Poisson distribution. Univariate and multivariate generalized linear models for singletons and generalized estimated equation models for all births were conducted to estimate the risk of perinatal mortality by ART status. Factors included in the multivariate models were ART status, maternal age, parity, BMI, Indigenous status, smoking during pregnancy and patient's insurance status. Odds ratio (OR), adjusted odds ratio (AOR) and 95% CI were calculated. We did not adjust for zygocity as data were not available. Data were analyzed using SPSS, version 20.0 (SPSS Inc., Chicago, Ill, USA).
Ethical approval
Ethics approval for this study was granted by the Human Research Ethics Committee of the University of New South Wales (HREC 11024) and the Australian Institute of Health and Welfare Ethics Committee (EC 2011/1/5).
Results
A total of 400 376 mothers (386 644 in non-ART group and 13 732 in ART group) gave birth to 407 368 babies (391 952 non-ART and 15 416 ART) during the study period (Table I) . ART mothers were more likely to be older, primiparous, privately insured and nonsmokers compared to non-ART mothers. Nearly half of the non-ART mothers were aged <30 years, while only 18% of non-ART mother were <30 years ( Table I) .
The multiple birth rate was significantly higher among ART (21.5%) compared to non-ART (2.7%) (P < 0.01). Preterm birth rates in ART and non-ART were 21.3% and 8.1%, respectively (P < 0.01). The rates of low birthweight were also significantly higher in ART compared to the non-ART (17.9% vs. 6.6%, P < 0.01) (Table II) .
Perinatal mortality rates in ART and non-ART groups were 16.5 per 1000 and 11.3 per 1000, respectively. Perinatal mortality rate for ART singletons was 11.6 per 1000 births and 10.5 per 1000 births for non-ART singletons. Perinatal mortality rate for ART twins was 30.9 per 1000 births and for non-ART twins 40.6 per 1000 births (Table III) . Gestational age-specific perinatal mortality was lower for ART preterm births than for non-ART preterm births (Fig. 1) . In births of <28 weeks gestation, the perinatal mortality rate was 548 per 1000 births in ART group and 732 per 1000 births in non-ART group (Fig. 1) .
Classification of cause of death was available for 58% (n = 1867) non-ART stillbirths and 58% (n = 85) ART stillbirths. Congenital abnormality (24%), maternal conditions (21%) and unexplained antepartum death (16%) were three most common causes in non-ART group, while congenital abnormality (21%), spontaneous preterm (20%) and unexplained antepartum death (22%) were the leading cause of stillbirth in ART group. 
Continued
Of the 1227 non-ART neonatal deaths, 554 (45%) had classification of perinatal death available. Of the 107 ART neonatal deaths, 48 (45%) had classification of perinatal death available. Congenital abnormality and spontaneous preterm were the most common causes of neonatal death in both ART and non-ART group.
Overall perinatal mortality was significantly higher for ART births, compared to non-ART births (AOR 1.45, 95% CI 1.26-1.68). However, gestational age-specific perinatal mortality of ART births was lower for very preterm (<32 weeks gestation) (AOR 0.61 95% CI 0.53-0.70) and moderate to late preterm births (32-36 weeks gestation) (AOR 0.63 95% CI 0.43-0.84), compared to non-ART births. For singletons, perinatal mortality for ART was 24% higher compared to non-ART (AOR 1.24 95% CI 1.04-1.48). The rate was significantly lower in very preterm ART singletons (<32 weeks gestation) compared to non-ART singletons (AOR 0.67 95% CI 0.54-0.82). Although perinatal mortality was lower in ART twins compared to non-ART twins, the difference was not statistically significant (AOR 0.82, 95% CI 0.60-1.11) (Table IV) .
Discussion
This large population-based cohort study in Australia compared perinatal mortality between ART and non-ART births. The higher rates of preterm birth among ART births contributed markedly to the overall higher perinatal mortality. ART singletons had a significantly higher perinatal mortality rate than non-ART singletons, while there was no significant difference in perinatal mortality rates for twins. Pregnant women following ART should receive extra care and education to prolong their pregnancy to term, in order to reduce perinatal mortality rate (Lambert, 2003; Ombelet et al., 2006; Pinborg et al., 2013) .
Perinatal mortality ART and non-ART singletons
The perinatal mortality rate for singletons born after ART treatment in Australia and New Zealand in 2009 was 12.3 per 1000 births compared to 9.3 per 1000 births among all births in Australia (Laws et al. 2010). As with previous studies we also reported higher rates of perinatal deaths among ART singletons compared with non-ART singletons (Helmerhorst et al., 2004; Ombelet et al., 2006) . The causes of high perinatal death among ART singletons have been explained by infertility-related factors such as older maternal age, nulliparity, medical co-morbidities, and recurrent miscarriages which are more prevalent among women undergoing ART compared to non-ART women (Schieve et al., 2007; Lisonkova et al., 2010; Pelkonen et al., 2010) . Therefore, infertile women who conceived naturally would be a more logical comparison group and have been shown to have higher rates of prenatal mortality than women without sub-fertility problem who conceive spontaneously (Thomson et al., 2005) . Other causes of high perinatal death among singletons may be related to ART treatment itself or drugs used for stimulation of the ovary (Lambert, 2003) . Patients undergoing ART treatment should be informed of the increased risk of perinatal death in singleton pregnancies.
Perinatal mortality ART and non-ART twins
Like previous studies (Fitzsimmons et al., 1998; Boulet et al., 2008; Declercq et al., 2015) , perinatal mortality rate in ART twins was lower compared to non-ART twins in our study. The cause of lower perinatal mortality among ART twins is not known however this may be due to low frequency of monozygotic twinning compared to naturally conceived twins. This may be explained by high incidence of twin-totwin transfusion syndrome in monozygotic twins compared to dizygotic twins (Umur et al., 2003; Al Riyami et al., 2013) . Monozygotic chorionic pregnancies should be identified early to intensify perinatal care and to manage modifiable risk factors (Sebire et al., 1997) . Increased surveillance for congenital anomalies in ART twin pregnancies and lower thresholds for early selective feticide would also reduce perinatal mortality and also explain the lower contribution of congenital anomaly to perinatal mortality in ART twins comparted with non-ART twins
Multiple births ART and non-ART
Higher proportion of multiples among ART births contributed markedly to the overall higher perinatal mortality among ART births compared with non-ART births. In our study twin birth rate in ART group was 20.4%, significantly higher than non-ART group (2.7%). Among all births, perinatal mortality was 38.4 per 1000 births in twins compared to 10.5 per 1000 births singletons. Studies suggested that multiple birth is the most notable adverse outcome following ART treatment and is responsible for the majority of perinatal deaths and other complications such as low birthweight, congenital anomaly, and infant morbidity and mortality (Elster, 2000; Koivurova et al., 2002; Rand et al., 2005) . The single greatest risk of multiple births (twins, triplets or more) following ART is the transfer of two or more embryos (Thurin et al., 2004) . In Australia, Reproductive Technology Accreditation Committee, the key industry regulatory body, advocated for the use of single embryo transfer ( Higher proportion of preterm births contribute to the excess perinatal mortality among ART births
Other common factors associated with higher perinatal mortality are preterm birth, extremely low birthweight, and older maternal age (Australian Institute of Health and Welfare, 2016). Gestational agespecific perinatal mortality rates in this study show that the higher rates of preterm birth largely account for the excess perinatal mortality among ART births. In contrast to other studies (Henningsen et al., 2014) , our study found that gestational age-specific perinatal mortality rate of ART births was lower for very preterm births compared to non-ART births in this study. (Henningsen et al., 2014) . They reported a higher risk of stillbirth in ART singletons delivered before 28 weeks, but not for higher gestational ages. This difference might be related to the timing and outcomes measures used in the two studies. Henningsen's study reported gestation-specific rates of stillbirth while we have reported perinatal deaths. Unlike Australia, these three Nordic countries exclude terminations of pregnancy from stillbirths (Mohangoo et al., 2011) . The more contemporaneous cohorts used in our study would have been screened in the second trimester for congenital anomaly have included more stillbirths following termination of pregnancy after week's gestation. In singletons, the overall increase in the effect of ART on perinatal mortality reflects gestation-specific effects and the relative frequency of each category of preterm birth. Perinatal mortality rates were higher in ART singletons, however gestation-specific perinatal mortality rates were no different or lower in ART compared to non-ART births. This shows that the higher perinatal mortality in ART may not be related to prematurity, but cause related to stillbirth. The rate of stillbirth was higher in the ART group (7.93 per 1000) compared to the non-ART group (7.73 per 1000).
Causes of death
Causes of death varied between stillbirth and neonatal deaths in our dataset. Among stillbirth, congenital abnormality, unexplained antepartum death and spontaneous preterm were common causes in ART group and congenital abnormality, maternal conditions and unexplained antepartum death were common causes in non-ART group. Among neonatal deaths, congenital abnormality and spontaneous preterm were common causes in both ART non-ART births. Many studies reported increased risk of congenital anomalies among singletons following ART treatment compared naturally conceived singletons (Hansen et al., 2005; Halliday et al., 2010; Davies et al., 2012) . Generally ART mothers are older compared to non-ART mothers and perinatal mortality due to congenital abnormalities increases with increasing maternal age (Australian Institute of Health and Welfare, 2016) . Causes of death also varied between singleton and multiple pregnancies.
There are limitations of the study. Information on ART use in the NPDC was available for five of eight states of Australia. We did not have all causes of mortality. However the classification of prenatal death has been adopted by all states and territories as a public health classification of perinatal death and has been validated internationally (Chan et al., 2004) . This study could not investigate or adjust for the impact of different types of ART treatments or embryo transfer practices on cause (fresh compared to frozen and single compared to double embryo transfer) or rates of perinatal mortality. For example, the risk of perinatal mortality is reported to be higher after frozen embryo transfer and lower after single embryo transfer (Sullivan et al., 2012) . The classification of prenatal death was only available for four states. Nor could we adjust for prior history of fetal death due to unavailability of data, which is considered as an important confounder. NPDC neonatal mortality is incomplete for babies transferred to another hospital for neonatal care. If ART mothers are more likely to give birth in tertiary centers than non-ART mothers then their babies are less likely to be transferred for care, resulting in undercounting of non-ART neonatal deaths.
Moreover, the results of this study should be interpreted with cautions for other countries due to varying definitions of perinatal period (Sullivan et al., 2013) . The definition of perinatal in NPDC is different from the WHO, the Centers for Disease Control and Prevention (CDC) and other countries. Perinatal definition for monitoring perinatal mortality in this study was 'infant deaths under age 28 days and fetal deaths at 20 weeks or more and/or ≥400 g of birthweight' (Australian Institute of Health and Welfare, 2015, 2016; MacDorman and Gregory, 2015) . According to the WHO, the perinatal period commences at 22 completed weeks (154 days) of gestation and ends seven completed days after birth (WHO, 2017) . The CDC uses two definitions for perinatal mortality. The definition for international and state-specific comparisons is, 'infant deaths under age 7 days and fetal deaths at 28 weeks of gestation or more ' (MacDorman and Gregory, 2015) . Similarly, European countries use various cut-off for gestational age in definition of perinatal mortality-some use ≥22 (Norway, France and Finland), while other use ≥24 (United Kingdom) or ≥28 weeks (Sweden and Denmark) (Sullivan et al., 2013) . However this may not impact the results as same definition and cut-off are used for ART and non-ART births. Finally we used data from 2007 to 2009 in this study and results may not be current due to continuously change in ART practice.
Monitoring of adverse perinatal outcomes is important while developing policies for various ART treatment procedures. Overall perinatal mortality is high due to an increased rate of multiple pregnancies after ART treatment. High perinatal mortality among the ART singleton is mainly due to high rates of preterm and low birthweight. These risks should be explained in the preconception counseling. A policy of single embryo transfer may significantly reduce perinatal mortality among the ART mothers.
